tiprankstipranks
CNBX Pharmaceuticals (CNBX)
OTHER OTC:CNBX
Holding CNBX?
Track your performance easily

CNBX Pharmaceuticals (CNBX) Income Statement

121 Followers

CNBX Pharmaceuticals Income Statement

Last quarter (Q ), CNBX Pharmaceuticals's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q, CNBX Pharmaceuticals's net income was $-60.58K. See CNBX Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Aug 24Aug 23Aug 22Aug 21Aug 20
Total Revenue
$ 130.07K$ 130.07K$ 410.17K$ 29.96K-$ 7.16K
Cost of Revenue
$ 6.22K-----
Gross Profit
$ 130.07K$ 130.07K$ 410.17K$ 29.96K-$ 7.16K
Operating Expense
$ 713.21K$ 713.21K$ 1.34M$ 2.98M$ 2.60M$ 3.05M
Operating Income
$ -583.14K$ -583.14K$ -931.38K$ -2.95M$ -2.60M$ -3.04M
Net Non Operating Interest Income Expense
$ -19.32K$ -19.32K$ -1.17K$ -1.27K$ -2.39K$ -8.13K
Other Income Expense
$ -23.12K$ -23.12K$ -52.62K$ -1.44M$ -594.27K$ 4.42M
Pretax Income
$ -583.14K$ -583.14K$ -931.38K$ -4.39M$ 126.51K$ -7.47M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -695.20K$ -695.20K$ -3.71M$ -4.39M$ -3.19M$ -7.47M
Basic EPS
$ -0.02$ -0.02$ -0.42$ -3.59$ -2.40$ -12.00
Diluted EPS
$ -0.02$ -0.02$ -0.42$ -3.59$ -2.40$ -12.00
Basic Average Shares
$ 120.99M$ 30.25M$ 8.82M$ 1.22M$ 1.15M$ 1.12M
Diluted Average Shares
$ 120.99M$ 30.25M$ 8.82M$ 1.22M$ 1.15M$ 1.12M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 719.43K$ 713.21K$ 1.34M$ 2.98M$ 2.60M$ 3.05M
Interest Expense
------
Net Income From Continuing And Discontinued Operation
$ -695.20K$ -695.20K$ -3.71M$ -4.39M$ -3.19M$ -7.47M
Normalized Income
$ -577.31K$ -577.31K--$ 587.30K-
EBIT
$ -649.11K$ -675.59K$ -3.71M$ -4.39M$ 128.90K$ -7.46M
EBITDA
$ -576.79K$ -603.27K$ -3.55M$ -4.19M$ 349.83K$ -7.24M
Currency in USD

CNBX Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis